XJPX
9267
Market cap663mUSD
Oct 09, Last price
3,455.00JPY
1D
0.58%
1Q
-8.11%
Jan 2017
22.74%
IPO
-17.54%
Name
Genky DrugStores Co Ltd
Chart & performance
P/E
13.37
P/S
0.48
EPS
258.37
Div yield, %
0.38%
Shrs. gr., 5y
0.11%
Rev. gr., 5y
9.16%
Revenues
220.64b
+9.89%
Net income
7.88b
+11.45%
CFO
16.98b
+34.75%
Dividend
Dec 17, 20266.5 JPY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Genky DrugStores Co., Ltd. engages in the management and operation of food and drug chain stores in Japan. Genky DrugStores Co., Ltd. was founded in 1988 and is headquartered in Sakai, Japan.
Key people
Kenichi Fujinaga
President, President of Subsidiary, Representative Director · since 2017
Takeshi Tsunemi
Executive Officer, Director of Finance and IR · since 2021
Yuji Kobayashi
Executive Officer, Chief Director of Main Human Resources Unit, Director · since 2020
Tatsuru Nakagawa
Director · since 2024
Hiroyuki Yamagata
Director · since 2018
Nobuhiro Yoshioka
Vice President, Director · since 2017
Junya Imai
Independent Director · since 2019
Yuichi Ishibashi
Independent Director · since 2025
Tomoyo Sasaki
Independent Director · since 2023
Miho Takeda
Independent Director · since 2023
Nana Yoshikawa
Independent Director · since 2023
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑06 | 2025‑06 | 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||